tradingkey.logo
tradingkey.logo
Search

Benitec Biopharma Inc

BNTC
Add to Watchlist
9.640USD
-0.190-1.93%
Close 09-24 16:00(ET)
331.13MMarket Cap
LossP/E TTM

BNTC Financials

See Benitec Biopharma Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
331.13M
Dividend TTM
0.00
P/E TTM
-10.43
EPS TTM
-0.92
Revenue
--
Net Profit
-37.92M
ROE
-29.58%
ROA
-28.43%

Benitec Biopharma Inc Earnings Date

Latest Release
Sep 14, 2026
EPS / Forecast
-0.26/-0.27
Revenue / Forecast
--/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q4
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Financial Indicators
EPS
33.96%-0.26
0.28%-0.24
22.74%-0.26
54.57%-0.22
34.65%-0.39
85.18%-0.24
87.37%-0.33
82.78%-0.48
78.81%-0.60
38.78%-1.64
20.94%-2.64
65.39%-2.76
---2.83
---2.67
---3.34
---7.98
----
----
----
----
Revenue
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--0.00
--7.00K
12.50%54.00K
-44.00%14.00K
--0.00
-100.00%0.00
4700.00%48.00K
2400.00%25.00K
-100.00%0.00
Net Profit
20.67%-12.81M
17.70%-11.94M
-60.89%-11.84M
-77.21%-8.96M
-202.43%-16.15M
-118.60%-9.35M
-8.22%-7.36M
15.03%-5.06M
-14.55%-5.34M
2.68%-4.28M
-25.63%-6.80M
-16.91%-5.95M
8.01%-4.66M
-34.26%-4.40M
-12.24%-5.41M
-0.95%-5.09M
-26.58%-5.07M
16.22%-3.27M
-48.25%-4.82M
-85.61%-5.04M
Net Margin
----
----
----
----
----
----
----
----
----
----
----
----
---66585.71%
---8142.59%
---38650.00%
----
----
----
----
----
Gross Margin
----
----
----
----
----
----
----
----
----
----
----
----
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
--0.00%
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
Revenue
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--0.00
--7.00K
12.50%54.00K
-44.00%14.00K
--0.00
-100.00%0.00
4700.00%48.00K
2400.00%25.00K
-100.00%0.00
Operating profit
15.99%-14.43M
11.43%-13.58M
-55.37%-13.38M
-69.28%-9.80M
-209.59%-17.18M
-146.03%-10.19M
-24.30%-8.61M
1.41%-5.79M
-21.93%-5.55M
4.61%-4.14M
-23.48%-6.93M
-28.25%-5.87M
3.97%-4.55M
-25.46%-4.34M
-16.03%-5.61M
5.02%-4.58M
-22.91%-4.74M
8.78%-3.46M
-48.36%-4.83M
-79.26%-4.82M
Net Profit
20.67%-12.81M
17.70%-11.94M
-60.89%-11.84M
-77.21%-8.96M
-202.43%-16.15M
-118.60%-9.35M
-8.22%-7.36M
15.03%-5.06M
-14.55%-5.34M
2.68%-4.28M
-25.63%-6.80M
-16.91%-5.95M
8.01%-4.66M
-34.26%-4.40M
-12.24%-5.41M
-0.95%-5.09M
-26.58%-5.07M
16.22%-3.27M
-48.25%-4.82M
-85.61%-5.04M
Current assets
84.42%181.69M
78.85%186.02M
140.87%189.59M
39.14%95.08M
90.65%98.52M
624.00%104.01M
278.50%78.71M
158.73%68.33M
1285.73%51.67M
94.27%14.37M
89.49%20.80M
54.63%26.41M
-22.63%3.73M
-16.36%7.39M
-13.39%10.97M
4.33%17.08M
-76.61%4.82M
-28.74%8.84M
-11.90%12.67M
103.23%16.37M
Total current liabilities
196.56%5.34M
-53.40%3.27M
-9.32%2.80M
-55.52%2.02M
-63.40%1.80M
104.42%7.03M
-46.24%3.09M
0.42%4.55M
23.78%4.92M
9.01%3.44M
130.86%5.75M
50.58%4.53M
57.11%3.98M
65.17%3.15M
0.36%2.49M
88.07%3.01M
84.95%2.53M
-21.89%1.91M
218.36%2.48M
57.11%1.60M
Total assets
83.37%182.62M
77.74%187.00M
141.16%190.68M
39.63%96.03M
90.75%99.59M
601.44%105.21M
270.29%79.07M
154.22%68.77M
1069.58%52.21M
82.47%15.00M
79.36%21.35M
49.34%27.05M
-25.26%4.46M
-18.32%8.22M
-15.05%11.90M
1.56%18.11M
-72.06%5.97M
-25.05%10.06M
-9.66%14.01M
100.04%17.84M
Total liabilities
144.23%5.61M
-51.98%3.67M
6.17%3.32M
-47.15%2.43M
-53.71%2.30M
118.32%7.64M
-46.85%3.13M
-3.18%4.59M
16.42%4.96M
-0.23%3.50M
102.10%5.88M
35.49%4.75M
37.88%4.26M
37.85%3.51M
-8.40%2.91M
48.33%3.50M
125.79%3.09M
1.84%2.54M
258.29%3.18M
100.08%2.36M
Total equity
81.93%177.01M
87.90%183.33M
146.72%187.36M
45.84%93.60M
105.92%97.30M
748.43%97.57M
390.89%75.94M
187.70%64.18M
23290.10%47.25M
144.01%11.50M
72.00%15.47M
52.66%22.31M
-92.99%202.00K
-37.33%4.71M
-17.00%8.99M
-5.57%14.61M
-85.60%2.88M
-31.20%7.52M
-25.91%10.84M
100.04%15.47M
Net operating income
39.86%-4.94M
-44.26%-4.45M
50.98%-3.78M
26.93%-3.35M
-149.41%-8.21M
49.97%-3.09M
-43.58%-7.70M
-0.20%-4.59M
19.58%-3.29M
-53.09%-6.17M
8.18%-5.37M
-13.15%-4.58M
15.65%-4.09M
-17.74%-4.03M
-74.73%-5.84M
5.45%-4.04M
5.86%-4.86M
-72.05%-3.42M
-0.54%-3.34M
-81.27%-4.28M
Net investment
---79.00K
-150.00%-15.00K
8.33%-11.00K
--0.00
--0.00
96.65%-6.00K
---12.00K
----
100.00%0.00
---179.00K
--0.00
--0.00
92.31%-1.00K
----
--0.00
--0.00
-109.22%-13.00K
100.00%0.00
100.00%0.00
100.00%0.00
Net financing
-90.53%241.00K
-98.21%506.00K
449.63%98.23M
-100.00%0.00
-93.65%2.54M
--28.41M
45725.64%17.87M
-22.44%21.66M
--40.07M
--0.00
--39.00K
74.33%27.92M
--0.00
--0.00
--0.00
--16.02M
-100.00%0.00
-100.00%0.00
----
----

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What are the current assets of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2026 earnings report, its current assets were 181.69M, with a year-on-year change of 84.42.

What are the total assets of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2026 earnings report, its total assets of Benitec Biopharma Inc were 182.62M, with a year-on-year change of 83.37.

What are the total liabilities of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2026 earnings report, its total liabilities of Benitec Biopharma Inc were 5.61M, with a year-on-year change of 144.23.

What is the total equity of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2026 earnings report, its total equity of Benitec Biopharma Inc was 177.01M, with a year-on-year change of 81.93.

What is the net operating income of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2026 earnings report, its net operating income of Benitec Biopharma Inc was -51.19M, with a year-on-year change of -22.57.

What is the net investment of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2026 earnings report, its net investment of Benitec Biopharma Inc was -105.00K, with a year-on-year change of -483.33.

What is the net financing of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2026 earnings report, its net financing of Benitec Biopharma Inc was 98.98M, with a year-on-year change of 40.42.

What is the Earnings Per Share (EPS) of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2026 earnings report, its Earnings Per Share (EPS) was -0.98, with a year-on-year change of 6.58.

What is the net income of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2026 earnings report, its net income was -45.55M, with a year-on-year change of -20.12.

What is the Return on Equity (ROE) of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2026 earnings report, its Return on Equity (ROE) was -33.21, with a year-on-year change of 36.70.

What is the Return on Assets (ROA) of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2026 earnings report, its Return on Assets (ROA) was -32.28, with a year-on-year change of 35.39.

What is the operating profit of Benitec Biopharma Inc?

According to Benitec Biopharma Inc's FY2026 earnings report, its operating profit was -51.19M, with a year-on-year change of -22.57.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.